The printing of three-dimensional tissue has taken a major step forward with the creation of a novel hybrid printer that simplifies the process of creating implantable cartilage.
Bio-based polymers have been largely limited to specialized niche applications, but a new analysis from Lux Research finds that the top markets for bio-based materials are largely the same ones currently dominated by petro-based materials.
Air Products’ PRISM® Membrane technology is enabling vehicles to run on methane at quasar energy group’s biomethane refueling facility in Columbus, Ohio. PRISM® PB Membrane modules are the key component of quasar’s biofueling plant, which uses anaerobic digestion to convert biogas generated from waste products into purified biomethane. The purified methane produced by quasar is currently fueling 25-50 municipal trucks, fleet vehicles, and non-commercial CNG vehicles every day.
Bioengineers at Harvard have developed a gel-based sponge that can be molded to any shape, loaded with drugs or stem cells, compressed to a fraction of its size, and delivered via injection. Once inside the body, it pops back to its original shape and gradually releases its cargo, before safely degrading.
After cellulose, xylan is the most abundant biomass material on Earth, and therefore represents an enormous potential source of stored solar energy for the production of advance biofuels. A major roadblock, however, has been extracting xylan from plant cell walls. Researchers with the U.S. Department of Energy (DOE)'s Joint BioEnergy Institute (JBEI) have taken a significant step towards removing this roadblock by identifying a gene in rice plants whose suppression improves both the extraction of xylan and the overall release of the sugars needed to make biofuels.
The University of Nottingham has been awarded funding of £2.9m to help make low-carbon fuel.
Smithers Rapra Publishing announces the release of Update on Life Cycle Strategy for New Implants and Medical Devices.
With the emergence of new therapies for diseases which affect vital organs either partially or as ...
Boston Scientific Corporation received CE Mark approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System featuring an ultra-thin abluminal (outer) bioabsorbable polymer coating. The SYNERGY Stent is the latest innovation in drug-eluting stent technology from Boston Scientific. It is unique in that its proprietary PLGA polymer and everolimus drug coating dissipate by three months. This innovation has the potential to improve post-implant vessel healing and will eliminate long-term polymer exposure, a possible cause of late adverse events.
Molex Incorporated will showcase the company’s MediSpec™ Micro-Miniature Coiling (MMC) capability designed for medical applications, including minimally invasive surgery, catheters and implanted devices at MD&M Minneapolis, October 30 through November 1, booth 1344. Constructed of biocompatible materials, MediSpec MMC features a continuous length coil enabling extrusion of micro gauge (50 to 26 AWG class) wire at virtually infinite lengths.
Asynt Ltd. in conjunction with Innovative Physical Organic Solutions (IPOS), a research group based within the University of Huddersfield, UK, have cooperated over the last 2 years to develop a new generation of chemical reactor.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.